SSY GROUP (02005): Ammonium bromide hydrochloride has been approved for registration as an active pharmaceutical ingredient for use in marketed formulations.

15/09/2025

ShiSi Pharmaceutical Group (02005) announced that the group's Ammonium Bromide Hydrochloride has been approved by the China National Medical Products Administration for registration.

SSY GROUP (02005) announced that the group's Ambroxol Hydrochloride has been approved by the China National Medical Products Administration for registration as an active pharmaceutical ingredient in marketed preparations. Ambroxol Hydrochloride is an expectorant drug mainly used for treating respiratory diseases.

ZYLOXTB (02190) spent HKD 1.2923 million to repurchase 50,000 shares on September 15th.

BlackRock increased its holdings in SINOPEC SEG (02386) by 2,481,500 shares, at a price of approximately 7.3 Hong Kong dollars per share.

E Fund Fund increased its holding of CMSC (06099) by 1,589,600 shares, with a price per share of approximately HK$17.4.

ZYLOXTB (02190) spent HKD 1.2923 million to repurchase 50,000 shares on September 15th.

BlackRock increased its holdings in SINOPEC SEG (02386) by 2,481,500 shares, at a price of approximately 7.3 Hong Kong dollars per share.

E Fund Fund increased its holding of CMSC (06099) by 1,589,600 shares, with a price per share of approximately HK$17.4.